Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Stock Option (Right to Buy) | Award | $0 | +5.05K | $0.00 | 5.05K | Aug 5, 2024 | Common Stock | 5.05K | $83.75 | Direct | F1 | |
transaction | MRNA | Stock Option (Right to Buy) | Award | $0 | +4.07K | $0.00 | 4.07K | Aug 5, 2024 | Common Stock | 4.07K | $83.75 | Direct | F2 | |
transaction | MRNA | Restricted Stock Units | Award | $0 | +850 | $0.00 | 850 | Aug 5, 2024 | Common Stock | 850 | Direct | F3, F4 | ||
transaction | MRNA | Restricted Stock Units | Award | $0 | +677 | $0.00 | 677 | Aug 5, 2024 | Common Stock | 677 | Direct | F3, F5 |
Id | Content |
---|---|
F1 | This option will become fully vested and exercisable on August 5, 2025. |
F2 | This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |
F3 | Restricted stock units convert into common stock on a one-for-one basis. |
F4 | The shares subject to this restricted stock unit award will vest in full on August 5, 2025. |
F5 | The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |